As accumulating evidence has shown that increased proinflammatory cytokines such as TNF-α, IL-23, and IL-6 are detected in inflamed mucosa of IBD patients [27], we explored whether these cytokines could regulate WISP1 expression in IBD LPMCs. This evidence concerns the gene IL6 and inflammatory bowel disease.